MEDIDERMA® MELA 360 SPOT CORRECTOR SERUM for Clinic Ordering

How to Order MELA 360 for Clinics

MEDIDERMA® MELA 360 SPOT CORRECTOR SERUM is listed here for wholesale evaluation by clinics planning professional pigment-care inventory for dark spots and uneven tone. This page helps procurement teams assess how the 30 mL topical serum fits practice use, what documentation may be needed, and which safety points matter before purchase; MedWholesaleSupplies supports licensed accounts through vetted distributors and verified supply channels. For licensed clinics and healthcare professionals.

The serum is intended for intact skin within supervised aesthetic routines. Clinics typically evaluate whether it belongs in pre-peel preparation, post-procedure maintenance, or ongoing cosmetic brightening plans for hyperpigmentation (excess skin pigment), melasma (brown-gray facial patches), sun-related discoloration, and uneven tone. It should be introduced with clear staff instructions, sunscreen expectations, and adverse-reaction escalation steps.

Why it matters: Pigment routines are easier to supervise when product use, sun protection, and irritation control are planned together.

Product Overview and Indications

MEDIDERMA® MELA 360 SPOT CORRECTOR SERUM is a professional topical serum from Mediderma’s MELA 360 line. It is used as a cosmetic pigment-care product for visible blotchiness, dull tone, and localized discoloration concerns. The product is not presented here as a drug treatment for a disease, and clinic protocols should remain consistent with the current carton, insert, and local professional standards.

The formula is commonly positioned as a Mediderma depigmenting serum for aesthetic programs that need a targeted, layer-friendly product. It can sit within broader routines that include gentle cleansing, barrier support, and daily photoprotection. For adjacent professional skincare assortment planning, clinics can browse the Mediderma brand hub, the Creams And Serums category, and the broader Skincare catalog.

In practice, the MELA 360 Spot Corrector Serum is most relevant when staff need a focused product for maintenance between procedures. It should not replace evaluation of changing lesions, medication-related pigment changes, or inflammatory skin disease. A clear intake process helps separate cosmetic discoloration goals from concerns that require medical diagnosis.

Eligibility and Ordering Requirements

Clinic-only procurement should be assigned to staff who can verify facility credentials, maintain product records, and coordinate use with the supervising provider. The product page is written for professional purchasing decisions, not consumer self-selection. Facilities should check whether local rules require specific documentation before retail dispensing or inclusion in post-procedure kits.

• Account verification: keep clinic license and facility details current.
• Protocol owner: identify the provider responsible for pigment-care routines.
• Inventory records: track lot, expiry, and internal location.
• Staff counseling: standardize sunscreen and irritation guidance.
• Patient screening: document allergy history and recent procedures.

Teams building a complete treatment room workflow may also find the Esthetician Supplies Checklist useful for non-product operational planning.

Prescription, Pricing and Access

This topical cosmetic serum is not described here as a prescription medicine. Professional facilities should still follow local sale, delegation, and documentation rules. The Mediderma MELA 360 price shown to a facility can depend on account status, volume terms, and current catalog conditions; B2B clinic accounts are verified before professional purchase terms are shown.

Procurement teams should evaluate acquisition terms alongside protocol fit, staff training needs, and expected rotation. A serum that appears appropriate on ingredient profile may still be unsuitable for a specific treatment pathway if the clinic cannot monitor irritation, photoprotection adherence, or product overlap with peels and retinoids.

Forms, Strengths, and Packaging

MEDIDERMA® MELA 360 SPOT CORRECTOR SERUM is supplied as a 30 mL dropper bottle in retail packaging with product information. No pharmaceutical strength is stated for this cosmetic serum; clinics should verify the active ingredient list and directions on the current unit before dispensing. Reference SKU 89891 when coordinating internal procurement records.

The compact format supports in-clinic retail shelving, backbar demonstration, and inclusion in supervised home-care kits. Availability of specific lots or packaging presentations may vary, so staff should confirm the unit received against internal protocol notes.

Composition and Ingredient Notes

Mediderma Mela 360 ingredients center on cosmetic brightening and tone-support actives. The current formula is commonly associated with tranexamic acid, vitamin C, niacinamide, and phytic acid. Ingredient lists can change, so the carton and insert should be treated as the controlling source for clinic records.

• Tranexamic acid: supports cosmetic routines for uneven-looking tone.
• Vitamin C: provides antioxidant support linked to brighter-looking skin.
• Niacinamide: helps barrier function and visible blotchiness management.
• Phytic acid: offers gentle chelating and brightening support.

The manufacturer positions the line as a liposomal pigment-care range, which is why some teams search for it as a MELA 360 liposomal serum. For background on antioxidant selection in topical routines, see Antioxidants And Skincare.

Administration and Use in Practice

Use in practice should follow the product insert and the supervising provider’s protocol. The Mediderma spot corrector serum is typically placed after cleansing and before moisturizer or photoprotection when the protocol calls for that sequence. Staff should avoid giving patient-specific frequency changes unless authorized by the responsible clinician.

• Preconditioning phase: consider tolerance before procedures when appropriate.
• Maintenance phase: support tone goals between scheduled visits.
• SPF alignment: reinforce daily photoprotection with resources such as Md Ceuticals Sunscreen.
• Procedure spacing: reduce overlap with aggressive exfoliation windows.
• Documentation: note the regimen sequence and patient counseling points.

For broader context on discoloration workflows around exfoliating procedures, review Fade Dark Spots. The article can support staff education, but it should not override the clinic’s own protocol or the product insert.

Storage, Handling, and Clinic Logistics

Store and handle the serum according to the current carton and insert. In routine clinic operations, that means keeping the bottle capped, reducing unnecessary heat and light exposure, and avoiding contamination of the dropper tip during demonstrations. Staff should record lot numbers and expiry dates at receiving and again when units move into retail or kit inventory.

Dropper hygiene matters because product demonstrations can create repeated contact points. Demonstrate dispensing without touching the dropper to skin, gloves, counters, or treatment tools. If a unit appears damaged, leaking, discolored, or inconsistent with expected packaging, quarantine it for internal review before use.

Quick tip: Keep pigment-care retail units separate from backbar testers to reduce recordkeeping errors.

Contraindications, Warnings, and Monitoring

Do not use this product on broken, infected, or severely irritated skin. Known sensitivity to any listed ingredient should be treated as a reason to avoid use unless the supervising clinician determines otherwise. Clinics should screen for recent peels, laser procedures, retinoid escalation, dermatitis, and other factors that may increase irritation risk.

Monitoring should focus on tolerability, redness, burning, dryness, and any unexpected worsening of discoloration. Melasma and lentigines (sun spots) can recur or fluctuate, especially with ultraviolet exposure and hormonal triggers. Patients with changing, painful, bleeding, or atypical lesions should be referred for appropriate medical assessment rather than managed as routine cosmetic pigment concerns.

Adverse Effects and Safety

Common cosmetic tolerability issues may include mild stinging, redness, dryness, tightness, or transient peeling. These effects can be more likely when the MELA 360 dark spot serum is layered with exfoliating acids, retinoids, or recent resurfacing procedures. Staff should document onset, duration, products used concurrently, and any corrective steps authorized by the clinician.

Less common but more concerning reactions include swelling, hives, blistering, marked burning, or eye exposure with persistent discomfort. If these occur, discontinue use and follow the clinic’s adverse-event procedure. The response plan should include escalation to an appropriate healthcare professional when symptoms are severe, spreading, or not improving.

Drug Interactions and Cautions

Formal drug interaction tables are not usually applied to cosmetic topical serums in the same way as systemic medicines. Practical cautions still matter. The MELA 360 serum tranexamic acid, vitamin C, niacinamide, and phytic acid combination should be reviewed alongside other active skincare products to reduce avoidable irritation.

Pay particular attention to retinoids, alpha hydroxy acids, beta hydroxy acids, benzoyl peroxide, hydroquinone-containing regimens, and professional peels. Sequencing and recovery windows should be set by the responsible provider. For clinic teams using Mediderma exfoliating products, Mediderma Peel Products provides additional category context.

Compare With Alternatives

Compared with MEDIDERMA® MELA 360 SPOT CORRECTOR SERUM, alternative pigment-care products may differ in active profile, texture, SPF inclusion, or procedure timing. Selection should be based on the clinic’s protocol goals, patient tolerance, and the provider’s assessment. No alternative should be treated as interchangeable without reviewing its label and role in the regimen.

Clinics that carry multiple pigment-care lines should avoid presenting one serum as universally better. The practical question is which product matches the planned procedure series, skin tolerance, and follow-up capacity.

Availability and Substitutions

When MEDIDERMA® MELA 360 SPOT CORRECTOR SERUM is not available in the needed quantity, substitutions should be reviewed by the provider responsible for the protocol. A suitable substitute should match the intended cosmetic role, not just the broad category name. Ingredient overlap, irritation potential, SPF expectations, and patient instructions all need review before any change is made.

Inventory planning should also consider seasonality. Pigment-care demand often rises around peel programs, post-summer discoloration visits, and maintenance campaigns. Keep internal substitution notes specific enough that front-desk, treatment, and retail staff use the same language.

Authoritative Sources

The following sources support ingredient and manufacturer context. They do not replace the current product insert or clinic policy.

• Manufacturer product details are available from Mediderma MELA 360.
• Vitamin C background is summarized by NIH Vitamin C.
• Dermatology literature can be searched through PubMed Tranexamic Acid.

Completed facility purchases are handled with temperature-controlled handling when required and tracked US delivery.

This content is for informational purposes only and is not a substitute for professional medical advice.